| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.32B | -22.5% |
| Cost of Revenue | $1.09B | -10.5% |
| R&D Expense | $128.0M | -13.8% |
| SG&A Expense | $777.2M | -9.8% |
| Interest Expense | $349.8M | -37.8% |
| Pre-tax Income | -$2.89B | -428.4% |
| Income Tax | $21.5M | -4.3% |
| Net Income | -$2.92B | -376.7% |
| EPS (Basic) | -$12.45 | -373.4% |
| EPS (Diluted) | -$12.45 | -373.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.02B | -32.4% |
| Accounts Receivable | $494.0M | -16.6% |
| Inventory | $274.5M | -3.2% |
| Current Assets | $2.08B | -23.5% |
| Total Assets | $5.76B | -34.3% |
| Current Liabilities | $689.6M | -57.7% |
| Long-term Debt | $7.83B | -5.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $269.2M | -34.5% |
| Capital Expenditures | $99.7M | +28.0% |
| Investing Cash Flow | -$133.1M | -123.6% |
| Financing Cash Flow | -$513.9M | -387.2% |
| Free Cash Flow | $169.5M | -49.1% |
| Stockholders' Equity |
| -$4.16B |
| -234.6% |